Huiyi and stratifyd have reached strategic cooperation to jointly drive the intelligent digital marketing of pharmaceutical enterprises

Recently, a formal strategic cooperation agreement has been reached between the new business segment "Huimian digital technology" of Huimian medical group and the AI intelligent data analysis platform stratifyd, which will contribute new intelligent digital marketing solutions to the pharmaceutical industry In recent years, pharmaceutical companies have introduced the concept of "patient-centered" into the market strategy, especially after the launch of "4 + 7" and other new procurement policies, the hospital market with greater patient voice determines that pharmaceutical companies pay more attention to patient groups In addition, as patients are more and more deeply involved in the selection of treatment methods and the evaluation of treatment results, the voice and strength of patients have more and more influence on the medical industry For pharmaceutical enterprises, to understand patients' views on drugs, to understand the reasons related to patients' compliance with drugs, and to deeply understand patients' needs can provide valuable reference for pharmaceutical enterprises to make decisions on new product research and development, drug quality monitoring, drug sales strategies, etc Patient group insight research has been more mature in foreign countries Research and service for patients is an important direction of foreign pharmaceutical market departments and medical departments It is reported that research and service for patients' behavior often account for 10-20% of the promotion budget They pay more attention to the analysis of patients' external voice and behavior, including the analysis of patients' consideration of drug efficacy, adverse reactions, drug economy, etc., positioning patients' groups and making patient portraits, so as to insight into patients' internal needs, adjust product related strategies accordingly, ultimately better serve patients, improve efficacy and accessibility, and reduce treatment The cost of treatment and the improvement of treatment experience are the end points PGI products are dedicated to solving the problem of patient group insight Generally speaking, there are two Market Research Solutions for the needs of patient group insight The first research solution is to form a direct understanding of patients by interviewing a large number of patients based on specific problems Or through a certain number of doctors, interviews based on specific issues, to form an indirect understanding of patients Doctors contact more patients at work They have a general understanding of the group voice of patients Through interviews based on doctors, we can quickly get the group portrait of patients The second research solution is "social listening", that is, crawling the network content with these keywords by setting keywords, using "Web Crawler" and other technical means, and then processing it manually, such as sorting out the crawling content, refining the medical content, making various charts and PPT for the conclusion, and finally forming the deliverables PGI (PatientGroupInsightSystem) is a patient listening and insight product jointly developed by Huizhu digital technology and AI data analysis platform manufacturer Stratifyd, which can help pharmaceutical companies to accurately understand the characteristics of patient groups PGI is based on the "social listening" method, adding artificial intelligence technology such as natural language understanding (NLP) and knowledge map, and more accurately mining the needs analysis, causal correlation and other insights behind the voice of patients in open channels For example, traditional technology to identify the keyword "headache" may produce many ambiguities, so that it is impossible to mine the real meaning of patients PGI can accurately identify the practical significance of the sentence with "headache" in the actual context For example, "headache after taking medicine" is to describe the side effects of patients' medication, "this medicine can alleviate headache" is to describe the disease symptoms of patients, "headache for drug price" is to describe the drug economy problems With the advantages of its own medical team and data science team, and in combination with stratifyd's industry-leading experience in natural language processing and automatic modeling, huievery Digital Technology Co., Ltd has contributed this AI data analysis platform, which is famous for its fast, flexible and powerful performance The strong combination of the two makes the project quickly and deeply implemented in the pharmaceutical field Compared with the previous two research methods, PGI can greatly improve automation, reduce manual work, and continuously monitor through the system At present, PGI has served a number of top20 multinational pharmaceutical companies For example, PGI has set up an engage platform for a mature drug of a large pharmaceutical company headquartered in Europe to understand the needs, interests, problems and other related contents of renal transplant patients, and further understand the needs, interests, problems and other related contents of renal transplant patients, so as to adjust the product related strategies and help to improve market share For another example, PGI has learned about the long-term survival and out of hospital management of patients in the overall diabetes market for a large pharmaceutical company headquartered in the United States, as well as doctors' awareness of the importance of out of hospital management, so as to help the marketing department of pharmaceutical enterprises to determine the focus on patients' survival and realize the long-term monitoring and effect evaluation of patients' education activities In addition to the pharmaceutical sector, PGI also contributes to the medical device sector By providing services to a large medical device company headquartered in the United States, we can help it understand the unmet needs and concerns of patients with bypass surgery, and finally understand and verify the clinical path of patients, key decision points and the basis for hospital doctors' selection It is a new business segment of Huizhu medical group to help pharmaceutical enterprises to realize digital and intelligent marketing decision-making with the joint efforts of strong and strong enterprises Huizhu mobile health business integration of Huizhu medical group's subordinate enterprises was incorporated into Huizhu medical group Based on the medical big data such as drug device data, disease information data, doctor image data, patient image data, clinical diagnosis and treatment data, Huiyi digital technology is committed to taking "digital technology" as the core, taking the leading technologies such as data science, marketing science, knowledge map, artificial intelligence as the main driving force to help the medical industry entities realize digitalization and intelligence Finally, we will reduce enterprise costs, improve user experience, increase industrial revenue and upgrade industrial models, and effectively use digital technology to drive medical and health enterprises to achieve innovative and intelligent development Huiyi's management team members come from IMS (now iqvia), veeva, IBM, Accenture, Tencent and other well-known global enterprises The team members are diverse, from the world's top universities and the domestic Qingbei re exchange, covering clinical medicine, pharmacy, life science, computer science, mathematical statistics, business management and other fields Huiyi has many years of digital and scientific and technological services for pharmaceutical enterprises Experience, the project type covers the informatization scenarios of various pharmaceutical enterprises from basic software, business application, frontier innovation, etc Huiyi's main team consists of medical team, development team and data science team Its core team members have more than ten years' experience in pharmaceutical enterprise service on average The enterprises served basically cover all foreign pharmaceutical enterprises in top20 and leading pharmaceutical enterprises in China Stratifyd is one of only three "coolvendor" in the analysis field evaluated by Gartner in 2018 Its powerful functions such as fast docking of external data, automatic training of semantic model to form AI algorithm and so on make it obtain orders from many Fortune 500 enterprises from the beginning of its birth Stratifyd's core text analysis function with the most competitive advantage is equipped with NLP, NLU and directional monitoring modules Based on AI technology, enterprises can effectively mine all channels of user feedback data information, so that enterprises can directly see the causes behind the problems through the phenomenon, and understand the emotional attitude and opinion intention of the target population With its strong algorithm and AI underlying technology, stratifyd has become a global data analysis solution provider for Lilly in 2017, and has signed contracts with a number of international pharmaceutical industry giants represented by GSK, the world's largest pharmaceutical group Stratifyd's strength background is also an important factor to facilitate the smooth cooperation between the two enterprises In the service process of D, the ability based on its own platform not only contributes to the accurate positioning of the important clinical problem points for the first-line pharmaceutical giants, but also integrates and analyzes the patient feedback data for the R & D and marketing of new drugs, successfully forecasts and makes decision-making reference for the new product market launch of pharmaceutical enterprises, greatly improves the market research efficiency of pharmaceutical enterprises and effectively assists pharmaceutical enterprises to achieve performance improvement, strati The cooperation between fyD and huimie is based on the common values and industry value driven concepts We hope that on the basis of successful experience accumulation, we can do more extensive application and driving practice in the pharmaceutical industry The signing ceremony of strategic cooperation between Huimian and stratifyd Huimian and stratifyd adhere to the common idea of data-driven industry change, and believe that the future pharmaceutical field must be a new business model with data and AI as the infrastructure This strategic cooperation between the two is an effective attempt to accelerate this trend and gather advanced experience In the near future, we will work together with stratifyd to contribute intelligent pharmaceutical solutions for different scenarios to the industry, and help the intelligent trend of the pharmaceutical industry to land smoothly As for the new business segment of Huishi medical group, Huishi mobile health business, a subsidiary of Huishi medical group, was integrated into Huishi HMH healthcare management services is a medical group company jointly funded by Hillhouse capital, an investment company known for its focus on long-term structural value investment, and mayoclinic, a well-known non-profit medical institution in the United States, in 2015 Jeni turtle